TULSA, Okla.--(BUSINESS WIRE)--GNUPharma®, a pioneer in the exploration and development of unique nutritional product solutions, stands poised to replace traditional thinking on limits of the human body’s response to supplements. After years of poring over research on the Endocannabinoid system, and several months of testing, we are proud to announce the launch of GnuEndo, a revolutionary new product line engineered to aid by supplementation in pain relief, weight loss, improved immunity and mood elevation by providing critical nutrition to the body’s endocannabinoid system.
The new product line includes GnuEndo Loss, GnuEndo Pain, GnuEndo Boost, GnuEndo Elevate and GnuEndo Sleep, each of which has been specially and carefully researched and developed from all natural herbs and ingredients, in fact every herb in the formulation can be bought over the counter. In testing, GnuEndo has proven to assist in helping to combat symptoms of depression by delivering nutrients that allow the body’s endocannabinoid system to elevate a user’s mood. Users with chronic pain have also reported nearly complete elimination of their symptoms within days of first use.
“After years of research, the GNUPharma team has created a supplemental formulation that provides nutrients to the body and appears to open the body’s existing pathways to the endocannabinoid system in a safe and natural way,” said GNUPharma Co-Founder and Chief Executive Officer Chip Paul.
GNUPharma will be debuting the GnuEndo line of products at the Southwest Cannabis Expo in Fort Worth, Texas this weekend. “The Cannabis community will be the first to understand the tremendous promise of the GnuEndo line of products,” said Paul.
More information about the products can be found on the company’s website at www.gnupharma.com.